Karachi: Abbott Laboratories (Pakistan) Limited has formally announced the resignation of Mr. Alejandro Granados Pozzo from his position as a member of the company’s Board of Directors, effective August 28, 2025. The company’s board has accepted his resignation and expressed its appreciation for his contributions during his tenure.

Abbott Laboratories (Pakistan) Limited, operating within the designated market category of pharmaceuticals, is expected to notify the Pakistan Stock Exchange regarding the appointment of a successor to Mr. Granados Pozzo’s position in due course. The company has committed to keeping all relevant parties, including the certificate holders of the exchange, informed about this development.

According to information available from the Pakistan Stock Exchange (PSX), Abbott Laboratories’ announcement marks a significant shift in the company’s governance structure, although no immediate impact on the company’s stock performance has been observed. The market will closely watch how the transition progresses and any potential implications it might have on Abbott Laboratories’ operations in Pakistan.

The resignation comes amid various changes within the corporate sector, reflecting broader trends in boardroom reshuffles and governance adaptations across different industries. Abbott Laboratories (Pakistan) Limited has assured stakeholders that the transition will be managed smoothly, ensuring continuity and stability in its operations.